<mets:mets xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" LABEL="Eprints Item" OBJID="eprint_97642" xmlns:mets="http://www.loc.gov/METS/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink"><mets:metsHdr CREATEDATE="2026-11-06T12:39:19Z"><mets:agent TYPE="ORGANIZATION" ROLE="CUSTODIAN"><mets:name>Arxiv Universal Publishings</mets:name></mets:agent></mets:metsHdr><mets:dmdSec ID="DMD_eprint_97642_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:titleInfo><mods:title>The Role and Importance of SGLT-2 Inhibitors in Cardioprotection</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Shakhzodbek Yormatov</mods:namePart><mods:namePart type="family">Shakhzodbek Yormatov</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>This article explores the emerging role of SGLT-2 inhibitors beyond their established use in diabetes management, focusing on their potential cardioprotective effects. SGLT-2 inhibitors, known for their ability to reduce glucose reabsorption in the kidneys, have shown promising impacts on cardiovascular health. By lowering blood glucose levels and blood pressure, they alleviate the workload on the heart, potentially improving cardiac structure and function. Moreover, their anti-inflammatory and antioxidant properties may further contribute to reducing cardiovascular risk. This annotation reviews current research on how SGLT-2 inhibitors influence heart failure and myocardial infarction outcomes, highlighting their dual benefits in managing both diabetes andcardiovascular diseases</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2024-06-29</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mets:xmlData></mets:mdWrap></mets:dmdSec><mets:amdSec ID="TMD_eprint_97642"><mets:rightsMD ID="rights_eprint_97642_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:useAndReproduction>
<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by its own author:</strong>
In self-archiving this collection of files and associated bibliographic
metadata, I grant Arxiv Universal Publishings the right to store
them and to make them permanently available publicly for free on-line.
I declare that this material is my own intellectual property and I
understand that Arxiv Universal Publishings does not assume any
responsibility if there is any breach of copyright in distributing these
files or metadata. (All authors are urged to prominently assert their
copyright on the title page of their work.)</p>

<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by someone other than its
author:</strong> I hereby declare that the collection of files and
associated bibliographic metadata that I am archiving at
Arxiv Universal Publishings is in the public domain. If this is
not the case, I accept full responsibility for any breach of copyright
that distributing these files or metadata may entail.</p>

<p xmlns="http://www.w3.org/1999/xhtml">Clicking on the <em>Deposit Item Now</em> button indicates your agreement to these
terms.</p>
    </mods:useAndReproduction></mets:xmlData></mets:mdWrap></mets:rightsMD></mets:amdSec><mets:fileSec><mets:fileGrp USE="reference"><mets:file SIZE="105944" MIMETYPE="application/pdf" ID="eprint_97642_19266_1" OWNERID="https://arxiv.universalpublishings.com/id/eprint/97642/1/Shakhzodbek_Yormatov_28-32.pdf"><mets:FLocat xlink:href="https://arxiv.universalpublishings.com/id/eprint/97642/1/Shakhzodbek_Yormatov_28-32.pdf" xlink:type="simple" LOCTYPE="URL"></mets:FLocat></mets:file></mets:fileGrp></mets:fileSec><mets:structMap><mets:div DMDID="DMD_eprint_97642_mods" ADMID="TMD_eprint_97642"><mets:fptr FILEID="eprint_97642_document_19266_1"></mets:fptr></mets:div></mets:structMap></mets:mets>